NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Ltd. (Marketer)

Apr 14, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on April 13, 2026, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Ltd. (Marketer).

It states that the price for each hard gelatin capsule containing: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets) has been fixed at Rs. 20.96/- excluding GST.

[Notification no. - 19(5099)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT